Clincosm LogoSign in Get a demo

Diabetes Mellitus, Type 1

Showing NaN - NaN of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2, Diabetes, Type 1 Trial in Toronto (a mail letter, a phone call and a phone call plus mailed letter)

Unknown status
  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus, Type 1
  • a mail letter, a phone call and a phone call plus mailed letter
  • Toronto, Ontario, Canada
  • +1 more
Apr 23, 2019

Diabetes, Type 1 Trial in Worldwide (Empagliflozin, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Escondido, California
  • +130 more
Dec 12, 2018

Diabetes, Type 1 Trial in Worldwide (Empagliflozin, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Montgomery, Alabama
  • +188 more
Oct 31, 2018

Hypoglycemia, Diabetes, Type 1 Trial in Canada, United States (G-Pen (glucagon injection), Lilly Glucagon (glucagon injection

Completed
Has Results
  • Hypoglycemia
  • Diabetes Mellitus, Type 1
  • G-Pen (glucagon injection)
  • Lilly Glucagon (glucagon injection [rDNA origin])
  • Birmingham, Alabama
  • +6 more
Sep 29, 2018

Celiac Disease, Diabetes, Type 1 Trial in Canada (Gluten Free Diet)

Completed
  • Celiac Disease
  • Diabetes Mellitus, Type 1
  • Gluten Free Diet
  • Hamilton, Ontario, Canada
  • +6 more
Sep 4, 2018

Diabetes, Type 1 Trial in Canada, United States (Otelixizumab)

Terminated
Has Results
  • Diabetes Mellitus, Type 1
  • Birmingham, Alabama
  • +16 more
Oct 11, 2017

Diabetes, Type 1 Trial in Worldwide (otelixizumab infusion plus physician determined standard of care, infusion plus physician

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • otelixizumab infusion plus physician determined standard of care
  • placebo infusion plus physician determined standard of care
  • Birmingham, Alabama
  • +108 more
Sep 5, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin detemir, NPH insulin, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin detemir
  • +2 more
  • Buenos Aires, Argentina
  • +99 more
Jan 30, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Little Rock, Arkansas
  • +181 more
Jan 16, 2017

Diabetes, Type 1 Trial in Toronto (50% bolus insulin correction, 100% bolus insulin correction, 150% bolus insulin correction)

Unknown status
  • Diabetes Mellitus, Type 1
  • 50% bolus insulin correction
  • +3 more
  • Toronto, Ontario, Canada
    LMC Bayview
Feb 17, 2017

Clinical Evaluation of BD NEXT Pen Needle

Completed
  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus, Type 1
  • BD NEXT 31G x 5 mm pen needle
  • +2 more
  • Toms River, New Jersey
  • +4 more
Feb 8, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (human insulin, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • human insulin
  • insulin aspart
  • Ciudad de Buenos Aires, Argentina
  • +94 more
Dec 20, 2016

Diabetes, Type 1 Trial in Toronto (ruboxistaurin, )

Completed
  • Diabetes Mellitus, Type 1
  • Toronto, Ontario, Canada
    For additional information regarding investigative sites for thi
Aug 25, 2016

Diabetes, Type 1 Trial in Canada, United States (Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Canagliflozin 100 mg
  • +2 more
  • Little Rock, Arkansas
  • +52 more
Jun 7, 2016

Diabetes, Type 1 Trial in Worldwide (Mixed Meal Tolerance Test, Glucagon Stimulation Test)

Completed
  • Diabetes Mellitus, Type 1
  • Mixed Meal Tolerance Test
  • Glucagon Stimulation Test
  • Los Angeles, California
  • +17 more
Jun 1, 2016

Diabetes, Type 1 Trial in Toronto (Vitamin D)

Completed
  • Diabetes Mellitus, Type 1
  • Vitamin D
  • Toronto, Ontario, Canada
    The Hospital for Sick Children
May 30, 2016

Diabetes, Type 1 Trial in Mississauga, Toronto (bant iPhone application)

Completed
  • Diabetes Mellitus, Type 1
  • bant iPhone application
  • Mississauga, Ontario, Canada
  • +1 more
Apr 18, 2016

Diabetes, Type 1 Trial in Toronto (BI 10773)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • BI 10773
  • Toronto, Ontario, Canada
    1245.46.10001 Boehringer Ingelheim Investigational Site
May 16, 2014

Diabetes, Type 1, Diabetes, Type 2, Asthma Trial in Worldwide (Technosphere Insulin)

Terminated
  • Diabetes Mellitus, Type 1
  • +2 more
  • Technosphere Insulin
  • Phoenix, Arizona
  • +77 more
May 3, 2012

Diabetes, Type 1 Trial in Worldwide (Subcutaneous Insulin, Inhaled Insulin)

Terminated
Has Results
  • Diabetes Mellitus, Type 1
  • Subcutaneous Insulin
  • Inhaled Insulin
  • Fullerton, California
  • +72 more
Feb 3, 2010

Diabetes, Type 1 Trial in Canada, United States (Inhaled human insulin)

Completed
  • Diabetes Mellitus, Type 1
  • Inhaled human insulin
  • Burlingame, California
  • +36 more
Feb 9, 2007

Diabetes, Type 1 Trial in Canada, United States (Inhaled human insulin)

Completed
  • Diabetes Mellitus, Type 1
  • Inhaled human insulin
  • Duarte, California
  • +34 more
Feb 9, 2007